Chronic cutaneous adverse events affected 8% of patients after checkpoint inhibitor therapy in a cohort study, often persisting for years.

Sorafenib as a single agent, although well tolerated, does not exhibit significant activity in the treatment of metastatic breast cancer (MBC ... hand–foot syndrome/skin reaction (45%).

Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma ...

Ashfaq Marghoob provides skin cancer care to the residents of Long Island at MSK’s dedicated skin cancer center in Hauppaugue. Most cases of squamous cell carcinoma can be cured when found early and ...

Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive drug that emits alpha ...

The following is a summary of “St Andrews Referral Delay in Skin Cancer (StARDISC): A study of keratinocyte skin cancer time ...